China's Share of Global Drug Trials Grows Significantly
RISEx · Originally posted 2026.11.04 13:27 (UTC)Key points
- In 2016, China conducted 5% of global innovative drug trials.
- By 2025, this figure is projected to rise to 30%.
- The US's share decreased from 45% to 33%.
- China leads in early-stage trials with 31% compared to the US's 27%.
In 2016, China ran 5% of the world’s innovative drug trials
By 2025: 30%. The US slipped from 45% to 33%
In early-stage trials, China is already ahead. 31% to 27%
Welcome back to our BlindSpot Series
Today: China’s biotech
https://x.com/risextrade/status/2117941699062509969?a=IKtxCN-k4wPshwhKNso&s=20
This post was rewritten by PerpDEX Hub from an official RISEx announcement. The original takes precedence for dates and figures. Not investment advice.
